Increase of coagulation potential in chronic spontaneous urticaria

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 66, Issue 3, 2011, Pages 428-433

  Takeda, T ^a   Sakurai, Y ^a   Takahagi, S ^b   Kato, J ^a   Yoshida, K ^a,c   Yoshioka, A ^a   Hide, M ^b   Shima, M ^a  

^a NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

chronic spontaneous urticaria; coagulation factor; hypercoagulative state; waveform analysis

Indexed keywords

D DIMER; FIBRIN; FIBRINOGEN; FIBRINOGEN DEGRADATION PRODUCT; PROTHROMBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CLOTTING; CHILD; CHRONIC URTICARIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FIBRIN FORMATION; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; CHILD; CHRONIC DISEASE; HUMANS; MIDDLE AGED; URTICARIA; YOUNG ADULT;

EID: 79551688466     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2010.02506.x     Document Type: Article

References (29)

1. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Gimenez-Arnau A, et al. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64: 1417-1426.
2. ODonnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW,. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997; 136: 197-201.
3. Hide M, Francis DM, Grattan CE, Hakimi J, Kochan JP, Greaves MW,. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993; 328: 1599-1604.
4. Kikuchi Y, Kaplan AP,. Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol 2001; 107: 1056-1062.
5. Parslew R, Pryce D, Ashworth J, Friedmann PS,. Warfarin treatment of chronic idiopathic urticaria and angio-oedema. Clin Exp Allergy 2000; 30: 1161-1165.
6. Chua SL, Gibbs S,. Chronic urticaria responding to subcutaneous heparin sodium. Br J Dermatol 2005; 153: 216-217.
7. Asero R, Tedeschi A, Cugno M,. Heparin and tranexamic acid therapy may be effective in treatment-resistant chronic urticaria with elevated D-dimer: a pilot study. Int Arch Allergy Immunol 2010; 152: 384-389.
8. Asero R, Tedeschi A, Riboldi P, Cugno M,. Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum. J Allergy Clin Immunol 2006; 117: 1113-1117.
9. Asero R, Tedeschi A, Coppola R, Griffini S, Paparella P, Riboldi P, et al. Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria. J Allergy Clin Immunol 2007; 119: 705-710.
10. Kaplan AP, Greaves M,. Pathogenesis of chronic urticaria. Clin Exp Allergy 2009; 39: 777-787.
11. Crawley JT, Lane DA,. The haemostatic role of tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol 2008; 28: 233-242.
12. Downey C, Kazmi R, Toh CH,. Novel and diagnostically applicable information from optical waveform analysis of blood coagulation in disseminated intravascular coagulation. Br J Haematol 1997; 98: 68-73. (Pubitemid 27348797)
13. Shima M,. Understanding the hemostatic effects of recombinant factor VIIa by clot wave form analysis. Semin Hematol 2004; 41: 125-131.
14. Sabroe RA, Fiebiger E, Francis DM, Maurer D, Seed PT, Grattan CE, et al. Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol 2002; 110: 492-499.
15. Takahagi S, Mihara S, Iwamoto K, Morioke S, Okabe T, Kameyoshi Y, et al. Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria. Allergy 2010; 65: 649-656.
16. Matsumoto T, Shima M, Takeyama M, Yoshida K, Tanaka I, Sakurai Y, et al. The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay. J Thromb Haemost 2006; 4: 377-384.
17. Roberts HR, Hoffman M, Monroe DM,. A cell-based model of thrombin generation. Semin Thromb Hemost 2006; 32 (Suppl 1): 32-38.
18. Schmaier AH,. The elusive physiologic role of Factor XII. J Clin Invest 2008; 118: 3006-3009.
19. Broze GJ Jr,. Tissue factor pathway inhibitor and the revised theory of coagulation. Annu Rev Med 1995; 46: 103-112.
20. Kauhanen P, Kovanen PT, Reunala T, Lassila R,. Effects of skin mast cells on bleeding time and coagulation activation at the site of platelet plug formation. Thromb Haemost 1998; 79: 843-847.
21. Lassila R, Lindstedt K, Kovanen PT,. Native macromolecular heparin proteoglycans exocytosed from stimulated rat serosal mast cells strongly inhibit platelet-collagen interactions. Arterioscler Thromb Vasc Biol 1997; 17: 3578-3587.
22. Wang F, Tang H, Xu JH, Kang KF,. Activation of the blood coagulation cascade is involved in patients with chronic urticaria. J Allergy Clin Immunol 2009; 123: 972-973. author reply 973-974.
23. Molino M, Barnathan ES, Numerof R, Clark J, Dreyer M, Cumashi A, et al. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem 1997; 272: 4043-4049.
24. Camerer E, Huang W, Coughlin SR,. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci USA 2000; 97: 5255-5260.
25. Riewald M, Ruf W,. Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor. Proc Natl Acad Sci USA 2001; 98: 7742-7747.
26. Jiang X, Bailly MA, Panetti TS, Cappello M, Konigsberg WH, Bromberg ME,. Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells. J Thromb Haemost 2004; 2: 93-101.
27. Takahagi S, Sindo H, Watanabe M, Kameyoshi Y, Hide M,. Refractory chronic urticaria treated effectively with the protease inhibitors, nafamostat mesilate and camostat mesilate. Acta Derm Venereol 2010; 90: 425-426.
28. Berth-Jones J, Hutchinson PE, Wicks AC, Mitchell VE,. Chronic urticaria with angio-oedema controlled by warfarin. BMJ 1988; 297: 1382-1383.
29. Barlow RJ, Greaves MW,. Warfarin in the treatment of chronic urticaria/angio-edema. Br J Dermatol 1992; 126: 415-416.